연구동향 분석

Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis

장우임 위성헌 김형욱 2015년

논문상세정보
인용/피인용
' Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • cefotaxime
  • cefuroxime
  • e. coli
  • pyelonephritis
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,720 1

0.0%

' Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis' 의 참고문헌

  • Use of gentamicin for women with community-acquired uncomplicated acute pyelonephritis caused by gentamicin-susceptible or -resistant Escherichia coli: 10-year experience
    Wie SH Microb Drug Resist 19 : 316 ~ 322 [2013]
  • Use of gentamicin for women with community-acquired uncomplicated acute pyelonephritis caused by gentamicin-susceptible or -resistant Escherichia coli: 10-year experience
    Wie SH Microb Drug Resist 19 316-322 [2013]
  • Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis
    Nicolle LE Urol Clin North Am 35 : 1 ~ 12 [2008]
  • Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis
    Nicolle LE Urol Clin North Am 35 1-12 [2008]
  • Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil
    Leigh DA J Antimicrob Chemother 23 : 267 ~ 273 [1989]
  • Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil
    Leigh DA J Antimicrob Chemother 23 267-273 [1989]
  • The sensitivity of urinary isolates to cefuroxime, a new beta-lactamase stable cephalosporin
    Roberts AP Curr Med Res Opin 7 : 5 ~ 13 [1980]
  • The sensitivity of urinary isolates to cefuroxime, a new beta-lactamase stable cephalosporin
    Roberts AP Curr Med Res Opin 7 5-13 [1980]
  • Pyelonephritis in adult women: inpatient versus outpatient therapy
    Safrin S Am J Med 85 : 793 ~ 798 [1988]
  • Pyelonephritis in adult women: inpatient versus outpatient therapy
    Safrin S Am J Med 85 793-798 [1988]
  • Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections
    Naber KG Int J Antimicrob Agents 19 : 95 ~ 103 [2002]
  • Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections
    Naber KG Int J Antimicrob Agents 19 95-103 [2002]
  • Performance standards for antimicrobial susceptibility testing: 15th informational supplement: approved standard MI00-S15
    Clinical and Laboratory Standard Institute Clinical and Laboratory Standards Institute [2005]
  • International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
    Gupta K Clin Infect Dis 52 : e103 ~ e120 [2011]
  • International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
    Gupta K Clin Infect Dis 52 e103-e120 [2011]
  • Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact
    Shin J Microb Drug Resist 18 : 169 ~ 175 [2012]
  • Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact
    Shin J Microb Drug Resist 18 169-175 [2012]
  • Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community
    Pitout JD J Antimicrob Chemother 56 : 52 ~ 59 [2005]
  • Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community
    Pitout JD J Antimicrob Chemother 56 52-59 [2005]
  • Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults:results of a prospective, investigator-blinded, randomized study
    Vazquez JA Curr Med Res Opin 28 : 1921 ~ 1931 [2012]
  • Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults:results of a prospective, investigator-blinded, randomized study
    Vazquez JA Curr Med Res Opin 28 1921-1931 [2012]
  • Diagnosis and management of acute pyelonephritis in adults
    Ramakrishnan K Am Fam Physician 71 : 933 ~ 942 [2005]
  • Diagnosis and management of acute pyelonephritis in adults
    Ramakrishnan K Am Fam Physician 71 933-942 [2005]
  • Declining cephalosporin and fluoroquinolone nonsusceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?
    Livermore DM J Antimicrob Chemother 68 : 2667 ~ 2674 [2013]
  • Declining cephalosporin and fluoroquinolone nonsusceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?
    Livermore DM J Antimicrob Chemother 68 2667-2674 [2013]
  • Complicated urinary tract infections
    Ronald AR Infect Dis Clin North Am 11 : 583 ~ 592 [1997]
  • Complicated urinary tract infections
    Ronald AR Infect Dis Clin North Am 11 583-592 [1997]
  • Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: a randomized, double-blind, multicenter trial
    Park DW J Korean Med Sci 27 : 476 ~ 483 [2012]
  • Comparison of Ertapenem and Ceftriaxone Therapy for Acute Pyelonephritis and Other Complicated Urinary Tract Infections in Korean Adults: A Randomized, Double-Blind, Multicenter Trial
    박대원 Journal of Korean Medical Science 27 5 476-483 [2012]
  • Clinical characteristics predicting early clinical failure after 72 h of antibiotic treatment in women with community-onset acute pyelonephritis:a prospective multicentre study
    Wie SH Clin Microbiol Infect 20 : O721 ~ O729 [2014]
  • Clinical characteristics predicting early clinical failure after 72 h of antibiotic treatment in women with community-onset acute pyelonephritis:a prospective multicentre study
    Wie SH Clin Microbiol Infect 20 O721-O729 [2014]
  • Clinical Microbiology Procedures Handbook
    York MK ASM press : 3.12.1 ~ 3.12.15 [2007]
  • Clinical Microbiology Procedures Handbook
    York MK 3.12.1-3.12.15 [2007]
  • Change of Antimicrobial Susceptibility among Escherichia coli Strains Isolated from Female Patients with Community-Onset Acute Pyelonephritis
    임승관 Yonsei Medical Journal 53 (1) : 164 ~ 171 [2012]
  • Change of Antimicrobial Susceptibility among Escherichia coli Strains Isolated from Female Patients with Community-Onset Acute Pyelonephritis
    임승관 Yonsei Medical Journal 53 1 164-171 [2012]
  • Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolates
    Jones RN Antimicrob Agents Chemother 12 : 47 ~ 50 [1977]
  • Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolates
    Jones RN Antimicrob Agents Chemother 12 47-50 [1977]
  • Cefuroxime, a new cephalosporin antibiotic: activity in vitro
    O’Callaghan CH Antimicrob Agents Chemother 9 : 511 ~ 519 [1976]
  • Cefuroxime, a new cephalosporin antibiotic: activity in vitro
    O’Callaghan CH Antimicrob Agents Chemother 9 511-519 [1976]
  • Appropriate antibiotic use for patients with urinary tract infections reduces length of hospital stay
    Spoorenberg V Clin Infect Dis 58 : 164 ~ 169 [2014]
  • Appropriate antibiotic use for patients with urinary tract infections reduces length of hospital stay
    Spoorenberg V Clin Infect Dis 58 164-169 [2014]
  • A change in the epidemiology of infections due to extended-spectrum beta-lactamase-producing organisms
    Rodriguez-Baño J Clin Infect Dis 42 : 935 ~ 937 [2006]
  • A change in the epidemiology of infections due to extended-spectrum beta-lactamase-producing organisms
    Rodriguez-Baño J Clin Infect Dis 42 935-937 [2006]